Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
NCT06944067
·
clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
NIH
Sponsor class
Conditions
Sickle Cell Disease
Sponsor
National Human Genome Research Institute (NHGRI)